After attending the AAAAI conference in the spring, the vital importance of epinephrine as the cornerstone treatment for anaphylaxis was really driven home. As I reported then: "Dr. F. Estelle Simons of the University of Manitoba, and the former president of the AAAAI, emphasized that epinephrine is on the WHO's worldwide approved list of drugs because there is no alternative. However, epinephrine delivery is fraught with error on all levels of treatment: from doctors, nurses and hospitals to...
